Q1 revenue exceeded estimates by ~5.7%, EBITDA beat by ~55%, Q2 guidance well above consensus. The combination of a revenue beat, improving margins, and a record launch backlog suggests accelerating growth and potential positive earnings revisions. Buy RKLB on the fundamental catalyst of strong earnings and guidance, with the largest launch deal underpinning future revenue visibility. Space industry execution risk, potential delays in Neutron development, or macro headwinds affecting space tech valuations.
Q1 revenue exceeded estimates by ~5.7%, EBITDA beat by ~55%, Q2 guidance well above consensus. The combination of a revenue beat, improving margins, and a record launch backlog suggests accelerating growth and potential positive earnings revisions. Buy RKLB on the fundamental catalyst of strong earnings and guidance, with the largest launch deal underpinning future revenue visibility. Space industry execution risk, potential delays in Neutron development, or macro headwinds affecting space tech valuations.